Zika virus (ZIKV) is a single-stranded RNA arbovirus belonging to the Flavivirus genus. 1,2 Similar to other zoonotic arboviruses, ZIKV is transmitted by the Aedes mosquito. It causes Zika fever, a usually non-fatal condition with symptoms including headache, fever, malaise, maculopapular rash, joint pains, and conjunctivitis. 2 Recently, it was revealed that ZIKV may have additional pathogenic effects on pregnant women and their fetuses. Reports from South America suggest that ZIKV infection during pregnancy causes fetal microcephaly, 2 which has negative impacts up to and including death. 2,3 In addition to mosquito-borne transmission, it has been reported that ZIKV may be transmitted through heterosexual intercourse, 2 with concomitant implications for global women's health. This is the first example of a mosquito-borne arbovirus that may also utilize a sexual route of transmission. This knowledge has initiated a massive effort by the translational science community to develop more effective detection methods and treatment strategies.Currently there are no approved vaccines or drugs for preventing or treating ZIKV infection or ZIKV-induced pathologies. Recent diagnostics development efforts have focused on ELISA and highly sensitive quantitative reverse transcription PCR